Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, Patrick S., Thompson, Craig B.·2012·Cancer Cell
DOI 10.1016/j.ccr.2012.02.014

Cited by (1,011)

Items 701–800 of 1,011

  1. Measuring intratumor heterogeneity by network entropy using RNA-seq data
    Youngjun Park, Sangsoo Lim, Jin‐Wu Nam, Sun Kim · 2016 · Scientific Reports
  2. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells
    Jia Qu, Wenyi Sun, Jie Zhong, Hao Lv, Mingrui Zhu, Jun Xu, Nan Jin, Zuoquan Xie, Minjia Tan, Shuhai Lin et al. · 2017 · The Journal of Cell Biology
  3. Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation
    Lina Zhou, Zhichao Wang, Chunxiu Hu, Chaoqi Zhang, Petia Kovatcheva‐Datchary, Di Yu, Shasha Liu, Feifei Ren, Xiaolin Wang, Yanli Li et al. · 2018 · Journal of Proteome Research
  4. S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2
    Lili Liu, Lei Qi, Teresa Knifley, Dava West Piecoro, Piotr G. Rychahou, Jinpeng Liu, Mihail I. Mitov, Jeremiah Thomas Martin, Chi Wang, Jianrong Wu et al. · 2019 · Journal of Biological Chemistry
  5. Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia
    Wael Al Zoughbi, Martin Pichler, Gregor Gorkiewicz, Barbara Guertl‐Lackner, Johannes Haybaeck, Stephan Wenzel Jahn, Carolin Lackner, Bernadette Liegl‐Atzwanger, Helmut Popper, Silvia Schauer et al. · 2016 · Oncotarget
  6. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells
    Cong Hu, Bo Pang, Guangzhu Lin, Zhen Yu, Huanfa Yi · 2019 · British Journal of Cancer
  7. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes
    Arturo Valle‐Mendiola, Isabel Soto‐Cruz · 2020 · Cancers
  8. Tumor‐associated macrophage interleukin‐β promotes glycerol‐3‐phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells
    Jian Lu, Zhongye Xu, Hubin Duan, Hongming Ji, Zigang Zhen, Bo Li, Huangsuo Wang, Huoquan Tang, Jie Zhou, Tao Guo et al. · 2020 · Cancer Science
  9. The Glyoxalase System—New Insights into an Ancient Metabolism
    Jakob Morgenstern, Marta Campos, Peter P. Nawroth, Thomas Henry Fleming · 2020 · Antioxidants
  10. PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
    Qi Zhou, Leijia Li, Feifei Sha, Yiming Lei, Xuan Tian, Lingjun Chen, Yan Chen, Huiling Liu, Yunwei Guo · 2023 · Cancer Research
  11. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications
    Xiangli Jiang, Qian Sun, Hui Li, Kai Li, Xiubao Ren · 2013 · International Journal of Cancer
  12. Mitochondria as Oxidative Signaling Organelles in T-cell Activation: Physiological Role and Pathological Implications
    Marcin M. Kamiński, Daniel Röth, Peter H. Krammer, Karsten Gülow · 2013 · Archivum Immunologiae et Therapiae Experimentalis
  13. Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review
    Danielle Barbosa Brotto, Ádamo Davi Diógenes Siena, Isabela Ichihara de Barros, Simone da Costa e Silva Carvalho, Bruna Rodrigues Muys, Lucas Goedert, Cibele Campos Cardoso, Jéssica Rodrigues Plaça, Anelisa Ramão, Jeremy Andrew Squire et al. · 2020 · Tumor Biology
  14. Reciprocal Regulation of AMP-activated Protein Kinase and Phospholipase D
    Suman Mukhopadhyay, Mahesh Saqcena, Amrita Chatterjee, Avalon Garcia, María A. Frías, David A. Foster · 2015 · Journal of Biological Chemistry
  15. Tumor Metabolism of Malignant Gliomas
    Peng Ru, Terence Marques Williams, Arnab Chakravarti, Deliang Guo · 2013 · Cancers
  16. Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma
    Johannes Francois Fahrmann, Dmitry Grapov, Kwanjeera Wanichthanarak, Brian C. DeFelice, Michelle Salemi, William N. Rom, David R. Gandara, Brett S. Phinney, Oliver Fiehn, Harvey Ira Pass et al. · 2016 · Carcinogenesis
  17. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
    Xiaojia Huang, Xinhua Xie, Hua Wang, Xiangsheng Xiao, Lu Yang, Zhi Tian, Xiaofang Guo, Lijuan Zhang, Hailin Tang, Xiaoming Xie · 2017 · Journal of Experimental & Clinical Cancer Research
  18. CDK 2 positively regulates aerobic glycolysis by suppressing SIRT 5 in gastric cancer
    Zhenyong Tang, Lei Li, Yuntian Tang, Dongyi Xie, Kun Wu, Weiyuan Wei, Qiang Xiao · 2018 · Cancer Science
  19. Regulation of Cellular Metabolism by High-Risk Human Papillomaviruses
    Imelda Martínez-Ramírez, Adela Carrillo‐García, Adriana Contreras‐Paredes, Elizabeth Ortíz-Sánchez, Alfredo Cruz‐Gregorio, Marcela Lizano · 2018 · International Journal of Molecular Sciences
  20. Metabolic reprogramming and disease progression in cancer patients
    Laura Torresano, Cristina Nuevo‐Tapioles, Fulvio Santacatterina, Jose Manuel Cuezva · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  21. A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H2S oxidation
    Roshan Kumar, Aaron Paul Landry, Arkajit Guha, Victor Vitvitsky, Ho‐Joon Lee, Keisuke Seike, Pavan R. Reddy, Costas Andreas Lyssiotis, Ruma V. Banerjee · 2021 · Journal of Biological Chemistry
  22. A Systems Approach to Predict Oncometabolites via Context-Specific Genome-Scale Metabolic Networks
    Hojung Nam, Miguel A. Campodonico, Aarash Bordbar, Daniel R. Hyduke, Sangwoo Kim, Daniel Craig Zielinski, Bernhard Ørn Palsson · 2014 · PLoS Computational Biology
  23. Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma
    Alenoush Vartanian, Sameer Agnihotri, Mark R. Wilson, Kelly E. Burrell, Peter D. Tonge, Amir Alamsahebpour, Shahrzad Jalali, Michael S. Taccone, Sheila Mansouri, Brian J. Golbourn et al. · 2016 · Oncotarget
  24. Targeting tumor-associated acidity in cancer immunotherapy
    Ruben Lacroix, Elisa A. Rozeman, Marina P Kreutz, Kathrin Renner, Christian U. Blank · 2018 · Cancer Immunology Immunotherapy
  25. Role of purines in regulation of metabolic reprogramming
    Zhenwei Tang, Wenrui Ye, Haotian Chen, Xinwei Kuang, Jia Guo, Minmin Xiang, Cong Peng, Xiang Chen, Hong Liu · 2019 · Purinergic Signalling
  26. Deregulated transcription factors in cancer cell metabolisms and reprogramming
    Rajni Kant, Rajesh Manne, Mohammad Anas, Vasudevarao Penugurti, Tingjin Chen, Bo‐Syong Pan, Che-Chia Hsu, Hui‐Kuan Lin · 2022 · Seminars in Cancer Biology
  27. Association of cancer metabolism-related proteins with oral carcinogenesis – indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
    Martin R. Grimm, Marcel Cetindis, Max Lehmann, Thorsten Biegner, Adelheid Munz, Peter Teriete, Wiebke Kraut, Siegmar Reinert · 2014 · Journal of Translational Medicine
  28. Notch stimulates growth by direct regulation of genes involved in the control of glycolysis and the tricarboxylic acid cycle
    Věra Slaninová, Michaela Krafčíková, Raquel Pérez-Gómez, Pavel Steffal, Lukáš Trantı́rek, Sarah J. Bray, Alena Krejčı́ · 2016 · Open Biology
  29. An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis
    Ying Zhu, Suzane Ramos da Silva, Meilan He, Qiming Liang, Chun Lu, Pinghui Feng, Jae Ung Jung, Shou‐Jiang Gao · 2016 · PLoS Pathogens
  30. mTORC2 controls cancer cell survival by modulating gluconeogenesis
    Md. Wasim Khan, Dipsikha Biswas, Monisankar Ghosh, Sapan Mandloi, Saikat Chakrabarti, Partha Chakrabarti · 2015 · Cell Death Discovery
  31. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells
    Kai Zhou, Yueliang Yao, Zhicheng He, Cong Chen, Xiaoning Zhang, Kaidi Yang, Yuqi Liu, Qing Liu, Wenjuan Fu, Yaping Chen et al. · 2018 · Cell Death and Disease
  32. Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
    Álvaro Lahiguera, Petra Hyroššová, Agnès Figueras, Diana Garzón, Roger Moreno‐Justicia, Vanessa Soto‐Cerrato, Iain A. McNeish, Violeta Serra, Conxi Lázaro, Maria-Pilar Barretina-Ginesta et al. · 2020 · EMBO Molecular Medicine
  33. Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond
    Yasmine K. Abd El Fattah, Ahmed I. Abulsoud, Sherihan G. AbdelHamid, Nadia Μ. Hamdy · 2022 · International Journal of Biological Macromolecules
  34. Construction and investigation of breast‐cancer‐specific ceRNA network based on the mRNA and miRNA expression data
    Xionghui Zhou, Juan Liu, Wei Ting Wang · 2014 · IET Systems Biology
  35. Deletion of the Mitochondrial Chaperone TRAP-1 Uncovers Global Reprogramming of Metabolic Networks
    Sofia Lisanti, Michele Tavecchio, Young Chan Chae, Qin Liu, Angela K. Brice, Mathew L. Thakur, Lucia Raffaella Languino, Dario C. Altieri · 2014 · Cell Reports
  36. Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways
    Amrita Chatterjee, Suman Mukhopadhyay, Kaity Han-Yung Tung, Deven Patel, David A. Foster · 2015 · Cancer Letters
  37. A Mortalin/HSPA9-Mediated Switch in Tumor-Suppressive Signaling of Raf/MEK/Extracellular Signal-Regulated Kinase
    Pui–Kei Wu, Seung‐Keun Hong, Sudhakar Veeranki, Mansi S. Karkhanis, Dmytro Starenki, Jose Antonio Plaza, Jong‐In Park · 2013 · Molecular and Cellular Biology
  38. Attacking the supply wagons to starve cancer cells to death
    Elizabeth M. Selwan, Brendan T. Finicle, Seong Min Kim, Aimee L. Edinger · 2016 · FEBS Letters
  39. MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism
    Surendra Kumar Shukla, Venugopal Gunda, Jaime Abrego, Dhanya Haridas, Anusha Mishra, Joshua J. Souchek, Nina V. Chaika, Fang Yu, Aaron R. Sasson, Audrey J. Lazenby et al. · 2015 · Oncotarget
  40. Mitochondria and Cancer: Past, Present, and Future
    Meghan L. Verschoor, Robert G. Ungard, Andrew Harbottle, John P. Jakupciak, Ryan L. Parr, Gurmit Singh · 2013 · BioMed Research International
  41. Lipid Droplets Define a Sub-Population of Breast Cancer Stem Cells
    Benjamin J. Hershey, Roberta Vazzana, Débora Joppi, Kristina M. Havas · 2019 · Journal of Clinical Medicine
  42. Role of tyrosine phosphorylation in modulating cancer cell metabolism
    Maria Letizia Taddei, Elisa Pardella, Erica Pranzini, Giovanni Raugei, Paolo De Paoli · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  43. Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
    Jin‐Kyoung Shim, Seonah Choi, Seon‐Jin Yoon, Ran Joo Choi, Junseong Park, Eun Hee Lee, Hye Joung Cho, Suji Lee, Wan‐Yee Teo, Ju Hyung Moon et al. · 2022 · Cancer Cell International
  44. Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification
    Lisette Potze, Simone Di Franco, Catarina Grandela, Mia L. Pras‐Raves, Daisy I. Picavet, Henk A. van Veen, Henk van LENTHE, Franziska B. Mullauer, Nicole N. van der Wel, Angela C. M. Luyf et al. · 2015 · Oncogene
  45. High mitochondria content is associated with prostate cancer disease progression
    Katharina Grupp, Karolina Jedrzejewska, Maria Christina Tsourlakis, Christina Koop, Waldemar Wilczak, Meike Adam, Alexander Quaas, Guido Sauter, Ronald Simon, Jakob Robert Izbicki et al. · 2013 · Molecular Cancer
  46. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition
    S. T. Kim, Su‐Young Kim, Samuel Jacob Klempner, Jin Young Yoon, N. Kim, Shinae Ahn, Heejin Bang, Kyoung‐Mee Kim, Woong‐Yang Park, Se Hoon Park et al. · 2016 · Annals of Oncology
  47. Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation
    Siqingaowa, Sathiya Sekar, Venkat Gopalakrishnan, Changiz Taghibiglou · 2017 · Biochemical and Biophysical Research Communications
  48. Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor Formation
    Mohsen Hosseini, L. Dousset, Walid Mahfouf, Martin Serrano-Sanchez, Isabelle Redonnet‐Vernhet, Samir Mesli, Zeinab Kasraian, Émilie Obre, Marc Bonneu, Stéphane Claverol et al. · 2018 · Cell Reports
  49. Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro
    Xiaoyi Chen, Zhijie Xu, Zhijian Zhu, Anqi Chen, Guanghou Fu, Yimin Wang, Hao Pan, Baiye Jin · 2018 · International Journal of Oncology
  50. The Tumor Microenvironment in Colorectal Cancer Therapy
    Leire Pedrosa, Francis María Esposito, Timothy M. Thomson, Joan Maurel · 2019 · Cancers
  51. Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division
    Ankur A. Gholkar, Keith A. Kwan Cheung, Kevin J. Williams, Yu‐Chen Lo, Shadia A. Hamideh, Chelsea Nnebe, Cindy Khuu, Steven J. Bensinger, Jorge Z. Torres · 2016 · Journal of Biological Chemistry
  52. A Biomimetic Plasmonic Nanoreactor for Reliable Metabolite Detection
    Jiangang Liu, Chenlei Cai, Yuning Wang, Yu Liu, Lin Huang, Tongtong Tian, Yuanyuan Yao, Wei Ping Jia, Ruoping Chen, Kun Zhang et al. · 2020 · Advanced Science
  53. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities
    Carina Neitzel, Philipp Demuth, Simon Wittmann, Jörg Fahrer · 2020 · Cancers
  54. Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells
    Xiao Li, Hongming Zhu, Weixuan Sun, Xingru Yang, Qing Hua Nie, Xuedong Fang · 2021 · Cancer Cell International
  55. PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
    Hao‐Wen Sim, Evanthia Galanis, Mustafa Khasraw · 2022 · Cancers
  56. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression
    Kequan Xu, Peng Xia, Xiangdong Gongye, Xiao Zhang, Shuxian Ma, Zhang Chen, Hao Zhang, Jie Liu, Yingyi Liu, Yonghua Guo et al. · 2022 · Molecular Metabolism
  57. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
    Danièl Thomas, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A. L. Thompson-Peach, Kelly SY Lim, Niklas Landberg, Thomas Köhnke, Nirmal Robinson, Satinder Kaur et al. · 2022 · Cancer Discovery
  58. The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2
    Nicoletta Guaragnella, Vanessa Palermo, Alvaro Galli, Loredana Moro, Cristina Mazzoni, Sergio Giannattasio · 2013 · FEMS Yeast Research
  59. Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH
    Eric L. Allen, Danielle Ulanet, David A. Pirman, Christopher E. Mahoney, John Coco, Yaguang Si, Ying Chen, Lingling Huang, Jinmin Ren, Sung E. Choe et al. · 2016 · Cell Reports
  60. Increased FNDC5/Irisin expression in human hepatocellular carcinoma
    Melania Gaggini, Manuela Cabiati, Serena Del Turco, Teresa Navarra, Paolo DE SIMONE, Franco Filipponi, Silvia Del Ry, Amalia Gastaldelli, Giuseppina Basta · 2016 · Peptides
  61. Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs
    Saqcena, M, Mukhopadhyay, S, Hosny, C, Alhamed, A, Chatterjee, A, Foster, D A · 2015 · Oncogene
  62. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
    Shin Pai, Vijesh Kumar Yadav, Kuang-Tai Kuo, Narpati Wesa Pikatan, Chun‐Shu Lin, Ming‐Hsien Chien, Wei‐Hwa Lee, Michael Hsiao, Shao‐Chih Chiu, Chi‐Tai Yeh et al. · 2021 · International Journal of Molecular Sciences
  63. Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson
    Kıvanç Birsoy, David M. Sabatini, Richard Possemato · 2012 · Nature Medicine
  64. Enriched Environment Inhibits Mouse Pancreatic Cancer Growth and Down-regulates the Expression of Mitochondria-related Genes in Cancer Cells
    Guohua Li, Yu Gan, Yingchao Fan, Yufeng Wu, Hechun Lin, Yanfang Song, Xiaojin Cai, Xiang Yu, Weihong Pan, Ming Yao et al. · 2015 · Scientific Reports
  65. Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma
    Juan Li, Shuchai Zhu, Jing Tong, Hui Hao, Jie Yang, Zhikun Liu, Yuxiang Wang · 2015 · Neuroreport
  66. Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring
    Myriam M. Chaumeil, Marina Radoul, Chloé Najac, Pia Eriksson, Pavithra Viswanath, Michael D. Blough, Charles Chesnelong, Hema Artee Luchman, John Gregory Cairncross, Sabrina M. Ronen · 2016 · NeuroImage Clinical
  67. PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
    Boyun Kim, Je Won Jung, Jaeyoung Jung, Youngjin Han, Dong Hoon Suh, Hee Seung Kim, Danny N. Dhanasekaran, Yong Sang Song · 2017 · Oncotarget
  68. Prospective study of blood metabolites associated with colorectal cancer risk
    Xiang Shu, Yong‐Bing Xiang, Nathaniel Rothman, Danxia Yu, Honglan Li, Gong Yang, Hui Cai, Xiao Ma, Qing Lan B, Yu‐Tang Gao et al. · 2018 · International Journal of Cancer
  69. SIRT3 elicited an anti‐Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis
    Lei Xu, Yang Li, Lixing Zhou, Robert Gregory Dorfman, Li Liu, Rui Cai, Chenfei Jiang, Dehua Tang, Yuming Wang, Xiaoping Zou et al. · 2019 · Cancer Medicine
  70. Mitochondrial health, the epigenome and healthspan
    Aon, Miguel A., Cortassa, Sonia, Juhaszova, Magdalena, Sollott, Steven J. · 2016 · Clinical Science
  71. EMT-induced metabolite signature identifies poor clinical outcome
    Salil Kumar Bhowmik, Esmeralda Ramirez‐Peña, James M. Arnold, Vasanta Putluri, Nathalie Sphyris, George C. Michailidis, Nagireddy Putluri, Stefan Ambs, Arun Sreekumar, Sendurai A. Mani · 2015 · Oncotarget
  72. Glucose-Based Regulation of miR-451/AMPK Signaling Depends on the OCT1 Transcription Factor
    Khairul I. Ansari, Daisuke Ogawa, Arun Kumar Rooj, Sean Edward Lawler, Anna M. Krichevsky, Mark D. Johnson, Ennio Antonio Chiocca, Agnieszka Bronisz, Jakub A. Godlewski · 2015 · Cell Reports
  73. Real‐Time Monitoring of Cancer Cell Metabolism and Effects of an Anticancer Agent using 2D In‐Cell NMR Spectroscopy
    He Wen, Yong An, Wen Jun Xu, Keon Wook Kang, Sunghyouk Park · 2015 · Angewandte Chemie International Edition
  74. Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions
    Hosein Rostamian, Mohammad Khakpoor-Koosheh, Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Mohammad Javad Tavassolifar, John M. Pawelek, Hamid Reza Mirzaei, Jamshid Hadjati · 2022 · BMC Cancer
  75. Molecular Pathways and Cellular Metabolism in Colorectal Cancer
    Hanne Røland Hagland, Marianne Berg, Ingunn W. Jolma, Arne Carlsen, Kjetil Søreide · 2013 · Digestive Surgery
  76. Hypoxia-Inducible Factor 1 Regulation through Cross Talk between mTOR and MT1-MMP
    Takeharu Sakamoto, Jane S. Weng, Toshiro Hara, Seiko Yoshino, Hiroko Kozuka‐Hata, Masaaki Oyama, Motoharu Seiki · 2013 · Molecular and Cellular Biology
  77. The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
    Aleco D’Andrea, Ilaria Gritti, Paola Nicoli, Marco Giorgio, Mirko Doni, Annalisa Conti, Valerio Bianchi, Lucia Casoli, Arianna Sabò, Alexandre Mironov et al. · 2016 · Oncotarget
  78. Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer
    Barbara Chiavarina, Marie‐Julie Nokin, Justine Bellier, Florence Durieux, Noëlla Blétard, Félicie Sherer, Pierre Lovinfosse, Olivier Peulen, Laurine Verset, Romain Dehon et al. · 2017 · International Journal of Molecular Sciences
  79. Nrf2‐Mediated Metabolic Reprogramming in Cancer
    Yanyang Wang, Juan Chen, Xiaoming Liu, Ren Zhao, Hong Zhe · 2018 · Oxidative Medicine and Cellular Longevity
  80. The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena
    Yijing Zhao, Lemeng Sun, Rachel R. Wang, Ji‐Fan Hu, Jiuwei Cui · 2018 · Critical Reviews in Oncology/Hematology
  81. Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer
    Steven C. Eastlack, Shengli Dong, Cristina Ivan, Suresh K. Alahari · 2018 · Molecular Cancer
  82. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer
    Jugang Wu, Hongjuan Chai, Xin Xu, Jiwei Yu, Yan Gu · 2020 · Molecular Oncology
  83. A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogen
    Manabu Kodama, Keiichi I. Nakayama · 2020 · BioEssays
  84. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression
    Yanan Zhang, Lu Zhao, Shizhou Yang, Yixuan Cen, Tingjia Zhu, Lingfang Wang, Lili Xia, Yuwan Liu, Jian Zou, Junfen Xu et al. · 2020 · Journal of Experimental & Clinical Cancer Research
  85. Elevated nuclear localization of glycolytic enzyme TPI1 promotes lung adenocarcinoma and enhances chemoresistance
    Peng Liu, Si-Jia Sun, Yingjie Ai, Xu Feng, Yi-Min Zheng, Yun Liang Gao, Jinye Zhang, Lei Zhang, Yiping Sun, Yue Xiong et al. · 2022 · Cell Death and Disease
  86. Profiling single cancer cell metabolism via high-content SRS imaging with chemical sparsity
    Yuying Tan, Haonan Lin, Ji‐Xin Cheng · 2023 · Science Advances
  87. Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
    Pouyan Ghaffari, Adil Mardinoğlu, Anna Asplund, Saeed Shoaie, Caroline Kampf, Mathias Uhlén, Jens Nielsen · 2015 · Scientific Reports
  88. HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
    Richard Andrew Burkhart, Danielle M. Pineda, Saswati N. Chand, Carmella Romeo, Eric R. Londin, Edward D. Karoly, Joseph A. Cozzitorto, Isidore Rigoutsos, Charles J. Yeo, Jonathan Robert Brody et al. · 2013 · RNA Biology
  89. Autophagy and cell reprogramming
    Shuo Wang, Pengyan Xia, Markus Rehm, Zusen Fan · 2015 · Cellular and Molecular Life Sciences
  90. Choline Metabolism Alteration: A Focus on Ovarian Cancer
    Marina Bagnoli, Anna Granata, Roberta Nicoletti, Balaji Krishnamachary, Zaver M. Bhujwalla, Rossella Canese, Franca Podo, Silvana Canevari, Egidio Iorio, Delia Mezzanzanica · 2016 · Frontiers in Oncology
  91. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma
    Xuan Wu, Jiliang Xia, Jingyu Zhang, Yinghong Zhu, Yangbowen Wu, Jiaojiao Guo, Shilian Chen, Qian Lei, Bin Meng, Chunmei Kuang et al. · 2020 · British Journal of Haematology
  92. Considerations for successful cancer immunotherapy in aged hosts
    Hurez, V, Padrón, Á S, Svatek, R S, Curiel, T J · 2016 · Clinical and Experimental Immunology
  93. Linking Cancer Metabolism to DNA Repair and Accelerated Senescence
    Elena V. Efimova, Satoe Takahashi, Noumaan A. Shamsi, Ding Wu, Edwardine Labay, Olesya A. Ulanovskaya, Ralph R. Weichselbaum, Sergey A. Kozmin, Stephen J. Kron · 2015 · Molecular Cancer Research
  94. Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
    Dongki Yang, Jaehong Kim · 2019 · Cells
  95. Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information
    Lina Mörén, A. Tommy Bergenheim, Soma Ghasimi, Thomas Brännström, Mikael Johansson, Henrik Antti · 2015 · Metabolites
  96. The role of mitochondrial electron transport in tumorigenesis and metastasis
    An S. Tan, James W. Baty, Michael V. Berridge · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
  97. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells
    Yong Won Choi, In Kyoung Lim · 2014 · Cancer Letters
  98. TP53 mutation, mitochondria and cancer
    William M. Kamp, Pingyuan Wang, Paul M. Hwang · 2016 · Current Opinion in Genetics & Development
  99. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
    Xiaoguang Li, Shuai Tang, Qianqian Wang, Elaine Lai‐Han Leung, Hongyue Jin, Yongzhuo Huang, Jia Liu, Meiyu Geng, Min Huang, Shengtao Yuan et al. · 2017 · Frontiers in Pharmacology
  100. Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity
    Ivy A. W. Ho, WINSTON S. N. SHIM · 2017 · BioMed Research International